CureSearch Announces Launch of Catapult Fund

For Immediate Release
Contact:
Trish Broome
Manager, Content Development
(240) 235-2292 | patricia.broome@curesearch.org
curesearch.org

Bethesda, Md – CureSearch for Children’s Cancer announced today the opening of the application window for a $1-2M (USD) Catapult Fund opportunity to support research into continued improvement in outcomes for pediatric cancer patients.

The Catapult Fund will provide funding support (as requested up to $1- 2M) for “clinic-ready” projects that fit the following parameters:

Phase 1 and Phase 2 human clinical trials: Proposed trials to test novel agents or combinations of agents or therapies. Trials to be considered may also utilize genomic, epigenetic and other molecular “omics” approaches for clinical marker discovery and clinical validation that will translate into diagnosis, prognosis and improved treatment of oncologic disease. All human trial protocols should include design elements that would generate data establishing both a “proof of principle” of human clinical activity, as well as to enable the testing of the technology in pediatric cancer patients.

For compelling “first in human” clinical studies, no more than 12 months of funding will be considered specifically to support pharmacodynamic, pharmacokinetic and/or non-human safety and toxicology studies. Continued funding will be dependent on meeting these milestones within the proposed timeline.

This grant opportunity is funded by CureSearch for Children’s Cancer to support the development of innovative, novel, and promising oncology research into human clinical trials and product commercialization with the ultimate goal of improving clinical outcomes in childhood cancer patients. CureSearch has particular interest in collaborative projects and/or research that leverage existing regulatory guidelines or governmental programs that require or reward research in the development of new therapies for pediatric patients.

The application window opens Monday, July 11 via Proposal Central, with award notifications released in February 2017. Funding will be provided 1 to 2 years, depending on the project. The complete Request for Applications is available here.

For more information about this grant opportunity or pediatric cancer research sponsored by CureSearch for Children’s Cancer, contact Sarita Sastry, PhD, National Director, Research and Programs, (240) 235-2215, research@curesearch.org.

###

CureSearch for Children’s Cancer

CureSearch for Children’s Cancer, a national nonprofit organization based in Bethesda, Md, works to end childhood cancer by driving targeted and innovative research with measurable results in an accelerated time frame. CureSearch is building a $10 million research pipeline to aggressively drive pediatric research grants and clinical trials that have a higher chance of becoming cures for children’s cancer without the toxic side effects that plague current treatment options.

For more information, visit curesearch.org, follow CureSearch on Twitter @curesearch or join the conversation on Facebook at www.facebook.com/curesearch.

Pin It on Pinterest

Scroll to Top